Patent=US4885238
Reddel R.R., Yang K., Rhim J.S., Brash D.E., Su R.T., Lechner J.F., Gerwin B.I., Harris C.C., Amstad P.
Immortalized human bronchial epithelial mesothelial cell lines.
Patent number US4885238, 05-Dec-1989
PubMed=2541616
Ke Y., Reddel R.R., Gerwin B.I., Reddel H.K., Somers A.N.A., McMenamin M.G., LaVeck M.A., Stahel R.A., Lechner J.F., Harris C.C.
Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma.
Am. J. Pathol. 134:979-991(1989)
PubMed=9533946; DOI=10.1165/ajrcmb.18.4.2943
Kahlos K., Anttila S., Asikainen T.M., Kinnula K., Raivio K.O., Mattson K., Linnainmaa K., Kinnula V.L.
Manganese superoxide dismutase in healthy human pleural mesothelium and in malignant pleural mesothelioma.
Am. J. Respir. Cell Mol. Biol. 18:570-580(1998)
PubMed=15920167; DOI=10.1016/S0002-9440(10)62492-3
Gordon G.J., Rockwell G.N., Jensen R.V., Rheinwald J.G., Glickman J.N., Aronson J.P., Pottorf B.J., Nitz M.D., Richards W.G., Sugarbaker D.J., Bueno R.
Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.
Am. J. Pathol. 166:1827-1840(2005)
PubMed=17331233; DOI=10.1186/1471-2164-8-62
Nymark P., Lindholm P.M., Korpela M.V., Lahti L., Ruosaari S., Kaski S., Hollmen J., Anttila S., Kinnula V.L., Knuutila S.
Gene expression profiles in asbestos-exposed epithelial and mesothelial lung cell lines.
BMC Genomics 8:62.1-62.14(2007)
PubMed=21454801; DOI=10.1165/rcmb.2010-0282OC
Shukla A., Barrett T.F., MacPherson M.B., Hillegass J.M., Fukagawa N.K., Swain W.A., O'Byrne K.J., Testa J.R., Pass H.I., Faux S.P., Mossman B.T.
An extracellular signal-regulated kinase 2 survival pathway mediates resistance of human mesothelioma cells to asbestos-induced injury.
Am. J. Respir. Cell Mol. Biol. 45:906-914(2011)
PubMed=22576795; DOI=10.3892/or.2012.1763
Ashinuma H., Takiguchi Y., Kitazono S., Kitazono-Saitoh M., Kitamura A., Chiba T., Tada Y., Kurosu K., Sakaida E., Sekine I., Tanabe N., Iwama A., Yokosuka O., Tatsumi K.
Antiproliferative action of metformin in human lung cancer cell lines.
Oncol. Rep. 28:8-14(2012)
PubMed=24926545; DOI=10.1097/JTO.0000000000000202
Riquelme E., Suraokar M.B., Rodriguez J., Mino B., Lin H.Y., Rice D.C., Tsao A., Wistuba I.I.
Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma.
J. Thorac. Oncol. 9:998-1007(2014)
PubMed=26011428; DOI=10.1111/cas.12698
Hakiri S., Osada H., Ishiguro F., Murakami H., Murakami-Tonami Y., Yokoi K., Sekido Y.
Functional differences between wild-type and mutant-type BRCA1-associated protein 1 tumor suppressor against malignant mesothelioma cells.
Cancer Sci. 106:990-999(2015)
PubMed=28553954; DOI=10.1038/onc.2017.147
Kato T., Sato T., Yokoi K., Sekido Y.
E-cadherin expression is correlated with focal adhesion kinase inhibitor resistance in merlin-negative malignant mesothelioma cells.
Oncogene 36:5522-5531(2017)
PubMed=33567673; DOI=10.3390/cancers13040685
Keller M., Reis K., Hjerpe A., Dobra K., Aspenstrom P.
Cytoskeletal organization correlates to motility and invasiveness of malignant mesothelioma cells.
Cancers (Basel) 13:685.1-685.20(2021)
PubMed=34663305; DOI=10.1186/s12935-021-02248-5
Sato T., Nakanishi H., Akao K., Okuda M., Mukai S., Kiyono T., Sekido Y.
Three newly established immortalized mesothelial cell lines exhibit morphological phenotypes corresponding to malignant mesothelioma epithelioid, intermediate, and sarcomatoid types, respectively.
Cancer Cell Int. 21:546.1-546.11(2021)